• Explore /
  • Poster
  • / A phase II trial of metformin and fluorouracil (MetFU) for patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard treatment.

A phase II trial of metformin and fluorouracil (MetFU) for patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard treatment.

Abstract Poster

Authors

null

Vanessa Costa Miranda

Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil

Vanessa Costa Miranda , Luiza Dib Faria , Maria Ignez Freitas Melro Braghiroli , Monica Jacobs , Jorge Sabbaga , Paulo Marcelo Hoff , Rachel Pimenta Riechelmann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01941953

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 601)

DOI

10.1200/jco.2014.32.3_suppl.601

Abstract #

601

Poster Bd #

D50

Abstract Disclosures

Similar Posters

First Author: Hideaki Bando

First Author: Zev A. Wainberg

First Author: Zev A. Wainberg

First Author: Kazuhisa Yamaguchi